Persistence of primary hyperparathyroidism: a single-center experience

[1]  L. Yip,et al.  How and when is multiglandular disease diagnosed in sporadic primary hyperparathyroidism? , 2022, Surgery.

[2]  G. Felisati,et al.  Evaluation of Wisconsin and CaPTHUS Indices Usefulness for Predicting Monoglandular and Multiglandular Disease in Patients with Primary Hyperparathyroidism through the Analysis of a Single-Center Experience , 2021, International journal of endocrinology.

[3]  R. Yeh,et al.  Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review , 2021, Biomedicines.

[4]  J. Villar-del-Moral,et al.  Usefulness of the Wisconsin and CaPTHUS indices for predicting multiglandular disease in patients with primary hyperparathyroidism in a southern European population. , 2021, Gland surgery.

[5]  Brenessa Lindeman,et al.  Preoperative parathyroid localization does not improve surgical outcomes for patients with primary hyperparathyroidism. , 2020, American journal of surgery.

[6]  E. Akl,et al.  Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults. , 2013, The Cochrane database of systematic reviews.

[7]  D. Terris,et al.  Routine bilateral neck exploration and four‐gland dissection remains unnecessary in modern parathyroid surgery , 2018, Laryngoscope investigative otolaryngology.

[8]  I. Nilsson.  Primary hyperparathyroidism: should surgery be performed on all patients? Current evidence and residual uncertainties , 2018, Journal of internal medicine.

[9]  A. Bergenfelz,et al.  Predictors of multiglandular disease in primary hyperparathyroidism , 2018, Langenbeck's Archives of Surgery.

[10]  N. Manzini,et al.  Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease. , 2017, International journal of surgery.

[11]  F. Cianchi,et al.  Cost–benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism , 2017, Head & neck.

[12]  Marcel Jinih MB BCh,et al.  Focused Versus Bilateral Parathyroid Exploration for Primary Hyperparathyroidism: A Systematic Review and Meta-analysis , 2016, Annals of Surgical Oncology.

[13]  A. A. Semenov,et al.  Modified quick parathyroid hormone test in surgery of primary hyperparathyroidism , 2015 .

[14]  G. Dionigi,et al.  Sporadic multiple parathyroid gland disease—a consensus report of the European Society of Endocrine Surgeons (ESES) , 2015, Langenbeck's Archives of Surgery.

[15]  M. Barczyński,et al.  The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism. , 2015, Gland surgery.

[16]  S. Sidhu,et al.  No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism. , 2015, Annals of surgery.

[17]  M. Beland,et al.  The utility of 4-dimensional computed tomography for preoperative localization of primary hyperparathyroidism in patients not localized by sestamibi or ultrasonography. , 2015, Surgery.

[18]  N. Freedman,et al.  Localization of Parathyroid Adenoma by 11C-Choline PET/CT: Preliminary Results , 2014, Clinical nuclear medicine.

[19]  G. Hunter,et al.  4D-CT for Preoperative Localization of Abnormal Parathyroid Glands in Patients with Hyperparathyroidism: Accuracy and Ability to Stratify Patients by Unilateral versus Bilateral Disease in Surgery-Naïve and Re-Exploration Patients , 2014, American Journal of Neuroradiology.

[20]  Suresh Patel,et al.  Preoperative Localization of Parathyroid Adenomas Using 4-Dimensional Computed Tomography: A Pictorial Essay , 2013, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[21]  Herb Chen,et al.  Creation of a “Wisconsin Index” Nomogram to Predict the Likelihood of Additional Hyperfunctioning Parathyroid Glands During Parathyroidectomy , 2013, Annals of surgery.

[22]  A. A. Semenov,et al.  Minimally invasive surgery of primary hyperparathyroidism , 2012 .

[23]  D. Farley,et al.  Primary Hyperparathyroidism and Negative Tc99 Sestamibi Imaging: To Operate or Not? , 2012, Annals of Surgical Oncology.

[24]  J. Norman,et al.  Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. , 2012, Journal of the American College of Surgeons.

[25]  C. Sturgeon,et al.  Cost-effectiveness of parathyroidectomy for primary hyperparathyroidism. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[26]  T. Carling,et al.  4D Parathyroid CT as the Initial Localization Study for Patients with De Novo Primary Hyperparathyroidism , 2011, Annals of Surgical Oncology.

[27]  Q. Duh,et al.  Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? , 2010, Archives of surgery.

[28]  Q. Duh,et al.  The Value of Intraoperative Parathyroid Hormone Monitoring in Localized Primary Hyperparathyroidism: A Cost Analysis , 2009, Annals of Surgical Oncology.

[29]  M. Tublin,et al.  Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. , 2007, AJR. American journal of roentgenology.

[30]  Q. Duh,et al.  Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. , 2006, Archives of surgery.

[31]  S. Sugg,et al.  Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. , 2004, Surgery.

[32]  Q. Duh,et al.  Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. , 2003, Journal of the American College of Surgeons.

[33]  M. O'Doherty,et al.  99Tcm sestamibi — a new agent for parathyroid imaging , 1989, Nuclear medicine communications.